Navigation Links
Sirtris unveils promising, novel SIRT1 activators for treating diseases of aging
Date:11/28/2007

Cambridge, MA, November 28, 2007 - Sirtris Pharmaceuticals, Inc. (NASDAQ: SIRT), a biopharmaceutical company focused on discovering and developing small molecule drugs to treat diseases of aging, announced today that findings in the journal Nature demonstrate that Sirtris has developed novel drug candidates that offer a promising, new approach to treating diseases of aging, including Type 2 Diabetes, by targeting SIRT1, a gene that controls the aging process.

In November 2006, Sirtris scientists and Sirtris co-founder, Prof. David Sinclair from Harvard Medical School, published consecutive papers in the journals Cell and Nature showing that resveratrol, a SIRT1 activator found in red wine, could reduce the impact of a high fat diet, increase stamina two fold and significantly extend lifespan of mice. Unfortunately, it was estimated that a person would need to drink 1000 bottles of red wine to obtain an equivalent dose of resveratrol. Now, scientists at Sirtris have developed SIRT1 activating molecules that are chemically distinct from resveratrol and are 1000 times more potent.

"The new drug candidates represent a significant milestone because they are the first molecules that have been designed to act on genes that control the aging process. For this reason, we feel they have considerable potential to treat diseases of aging such as Type 2 Diabetes," said Christoph Westphal, M.D., Ph.D., Chief Executive Officer and Vice Chair of Sirtris Pharmaceuticals. "The breakthrough in potency we have achieved with the novel chemical entities (NCEs) means that we can obtain the health benefits of resveratrol with a considerably lower dose."

The Nature paper from Sirtris shows that in diet-induced obese and genetically obese mice, Sirtris small molecule NCEs improve insulin sensitivity, lower plasma glucose levels and increase the function of mitochondria (the powerhouses of all cells). In another well-established preclinical model of Type 2 D
'/>"/>

Contact: Sheryl Seapy
sheryl@purecommunicationsinc.com
949-608-0841
Pure Communications Inc.
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. EC unveils new EU maritime policy
2. Tumor genome analysis unveils new insights into lung cancer
3. MGH researchers describe new way to identify, evolve novel enzymes
4. Muscle mass: Scientists identify novel mode of transcriptional regulation during myogenesis
5. Novel 3-D cell culture model shows selective tumor uptake of nanoparticles
6. IdentiPHI Re Launches SAFmodule Software to Secure Novell(R) Networks
7. IdentiPHI Re Launches SAFmodule Software to Secure Novell(R) Networks
8. 454 Sequencing: Science paper describes a novel, highly efficient method of sequencing ancient DNA
9. Scientists discover novel way to remove iron from ferritin
10. Identification of a novel class of (not-so) small RNAs
11. A novel way found to prevent protein plaques implicated in Alzheimers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... from McGill University and the Quebec government have ... Canadian Journal of Fisheries and Aquatic Sciences ... household cleansers, or industrial cleansers, to which they ... small size and buoyancy, they may readily pass ... global contaminant in the world,s oceans, but have ...
(Date:9/18/2014)... DNA, tiny strands of nucleic acid that contain instructions ... genetic data, our DNA is copied into RNA molecules, ... tasks in our cells. , Several years ago, ... all other known RNAs, this molecule is circular, and ... little has been known about how they are produced. ...
(Date:9/18/2014)... from several disciplines will be celebrated tonight at the ... in improving the health of premature infants and in ... The researchers, whose work was supported by the National ... former Atomic Energy Commission, will be honored at a ... A bipartisan group of Members of Congress will be ...
Breaking Biology News(10 mins):Microplastic pollution discovered in St. Lawrence River sediments 2Scientists find how mysterious 'circular RNA' is formed, claim muscular dystrophy link 23rd annual Golden Goose award ceremony honors 8 researchers; Unusual work had big results 2
... NEW YORK, Dec. 14, 2010 Reportlinker.com announces that ... catalogue: Global Biochip Markets: Microarrays and ... INTRODUCTION  STUDY GOALS ... study was to determine the status of current and ...
... Sustainability is the theme for the 65th Annual International ... in Portland June 19 to 21. Hundreds of scientists, ... non-profit groups, and private industry will gather to discuss ... information about innovations in the field., "The theme of ...
... (June 10, 2011) The Academy of Natural Sciences ... FMC Corporation to help Philadelphia public middle school students and ... career opportunities in the sciences. The $25,000 grant from the ... Academy for some 800 6th through 8th graders and their ...
Cached Biology News:Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip 2Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip 3Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip 4Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip 5Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip 6Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip 7Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip 8Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip 9Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip 10Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip 11Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip 12Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip 13Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip 14Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip 15Grant funds science career days for Philadelphia public school students 2
(Date:9/19/2014)... CORAL SPRINGS, Florida , September 19, 2014 /PRNewswire/ ... biotech companies release latest developments, patents and results of ... (OTC: GNSZ), Eli Lilly and Company (NYSE: ... ), Celgene Corporation (NASDAQ: CELG ) and ... (OTCQB: GNSZ), a leader in developing prodrug therapeutics for ...
(Date:9/19/2014)... , September 19, 2014 ... 53rd European Society for Paediatric Endocrinology (ESPE) Meeting  ... science and medical research in the field of growth  ... KGaA, Darmstadt, Germany , today announced ... (GGI) for 2014. The awards were announced during a ...
(Date:9/18/2014)... About POCT POCT, ... clinical laboratory. It helps in making fast clinical ... medication. POCT is gaining popularity due to the ... as diabetes, heart disease, and obesity. It is ... to minimize errors during the diagnosis of patients. ...
(Date:9/18/2014)... DUBLIN, Ireland , September 18, ... ,Research and Markets ( http://www.researchandmarkets.com/research/czvg3s/biocompatible ) ... "Biocompatible Materials - Global Strategic ... offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ,This report ... Materials in US$ Million by the ...
Breaking Biology Technology:Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 2Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 3Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 4Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 5Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 6Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 7EMD Serono Awards Grant for Growth Innovation (GGI) for the First Time 2EMD Serono Awards Grant for Growth Innovation (GGI) for the First Time 3POCT Market in China 2014-2018 2Biocompatible Materials - Global Strategic Business Report 2014 2Biocompatible Materials - Global Strategic Business Report 2014 3
... Incorporated and Cedara Software Corp. are about ... software, particularly digital medical imaging. , ,Pending stockholder and regulatory ... Merge CEO Richard Linden will stay on as ... will stay on the board of directors. Merge offered 0.587 ...
... Madison could offer to the field of educational games over ... our coverage of last Thursday's public forum with three ... site. Our normal recurring readership is about 30,000 to 35,000 ... out-of-state and about 15 percent read the site internationally. , ...
... line up to promote human embryonic stem-cell research, policymakers and ... most likely answer is no. But among those states poised ... the best positioned for success. , ,Thats because the $750 ... at advancing stem-cell research alone, but an interdisciplinary mix of ...
Cached Biology Technology:International eyes drawn to Madison's games research 2International eyes drawn to Madison's games research 3International eyes drawn to Madison's games research 4Life-science research plan is about more than stem cells 2Life-science research plan is about more than stem cells 3
...
...
... Streptavidin Sepharose High Performance, 5 ml. ... used in HiTrap Streptavidin columns for ... for packing into Tricorn 5/50 GL, ... larger scale purifications are required.Extremely useful ...
Luminometers...
Biology Products: